As of June 20, 2025, Epizyme Inc (EPZM) reports a Graham Number of N/A.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Comparing Epizyme Inc's Graham Number to Peers
To better understand Epizyme Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Epizyme Inc (EPZM) | - |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Inhibrx Inc (INBX) | 155.78 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Amgen Inc (AMGN) | 43.25 |
Compared to its competitors, Epizyme Inc's Graham Number is difficult to compare due to insufficient data.